Results 81 to 90 of about 3,549 (185)

Comparison of the intact mass and polydispersity index of Neulasta® and Lupin’s Pegfilgrastim.

, 2023
Comparison of the intact mass and polydispersity index of Neulasta® and Lupin’s Pegfilgrastim.
Sanjay Niranjan (2139496), Tejshri Lakhote (16806776), Sanjay Tiwari (1669654), Bhavesh Vats (10737927), Arati Deshmukh (16806764), Kaustubh Dange (16806773), Ashok Mishra (16806782), Rishank Goyal (16806767), Jennifer Bharucha (16806779), Kalyana Sundaram (16806770)   +9 more
core   +1 more source

Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy

Haematologica, 2008
Quality and quantity of mobilized peripheral blood stem cells determine the safety of tandem autologous transplants in myeloma. Using the same mobilization chemotherapy with DT-PACE in two consecutive protocols, robustness of stem cell collection and ...
Guido Tricot, Bart Barlogie, Maurizio Zangari, Frits van Rhee, Antje Hoering, Jackie Szymonifka, Michele Cottler-Fox   +6 more
doaj   +1 more source

Proposed biosimilar pegfilgrastim (LA-EP2006) compared with reference pegfilgrastim in Asian patients with breast cancer: an exploratory comparison from two Phase III trials

, 2017
Aim: This is a pooled subgroup analysis of Asian patients enrolled in two Phase III confirmatory studies comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in women receiving chemotherapy for breast cancer.
Allen Nixon, Roumen Nakov, Nadia Harbeck, Yuhan Li, Clyde M Jones, Kimberly Blackwell, Pere Gascon, Andriy Krendyukov   +7 more
core   +1 more source

Quantification of the cellular content of platelet-rich plasma harvested after injection of filgrastim versus pegfilgrastim biosimilars: a prospective, single-center, crossover study

Journal of Cartilage & Joint Preservation
Introduction: Hematopoietic stem cells (HSCs) appear in peripheral blood (PB) following mobilization due to external events or pharmaceutical agents like filgrastim and pegfilgrastim.
Mohammadreza Abbasian, Eric Branch, Ali Parsa, Jessica Truett, Joshua J. Cook, Charlkesha A. Rahming, Adam W. Anz   +6 more
doaj   +1 more source

Randomized Phase III Trial of Pegfilgrastim versus Filgrastim after Autologus Peripheral Blood Stem Cell Transplantation

, 2010
Nonrandomized trials suggest that pegfilgrastim, a pegylated granulocyte colony-stimulating factor, could be used in lieu of filgrastim after autologus peripheral blood stem cell transplantation.
Rodriguez, Tulio, Kiley, Karen, Hicks, Chindo, Toor, Amir, Dawravoo, Kevin, Fletcher-Gonzalez, Donna, Stiff, Patrick, Smith, Scott, Fox-Geiman, Mary, Gerds, Aaron, Toor, Amir, MD   +10 more
core   +1 more source

A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices

, 2022
PURPOSE: We evaluated the incidence of febrile neutropenia (FN) and related clinical outcomes among patients treated with myelosuppressive chemotherapy for nonmyeloid malignancies who received pegfilgrastim on-body injector (OBI) or other options (Other)
Gawade, Prasad L., Crawford, Jeffrey, DeCosta, Lucy, Narang, Mohit, Dale, David C., MacLaughlin, William W., Lawrence, Tatiana, Rifkin, Robert M., Mahtani, Reshma L., Belani, Rajesh, Huynh, Chanh, Lewis, Sandra   +11 more
core   +1 more source

Incidence of myelodysplastic syndromes in patients receiving concurrent myelosuppressive chemotherapy and pegfilgrastim

, 2010
Background. The World Health Organization classifies myelodysplastic syndromes (MDS) as a group of hematologic malignancies where at least one myeloid lineage contains ≥10% cells with myelodysplasia. Therapy-related MDS (t-MDS) may result from treatment
Wendy M Covert, Jose R Murillo, James E Cox   +2 more
core   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Enitociclib (VIP152), venetoclax and prednisone in relapsed or refractory aggressive non‐Hodgkin lymphoma

British Journal of Haematology, Volume 208, Issue 1, Page 308-311, January 2026.
Max J. Gordon, Rahul Lakhotia, Stefania Pittaluga, Svetlana D. Pack, Anna Marie Juanitez, Ahmed Hamdy, Amy J. Johnson, Melanie M. Frigault, Raquel Izumi, Mark Raffeld, Mark Roschewski, Wyndham H. Wilson, Christopher Melani   +12 more
wiley   +1 more source